NURS 6521 Week 4 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Course and Assessment Context

Course: NURS 6521 – Advanced Pharmacology

Institution model: Walden-style online graduate nursing program (U.S. college, MSN level)

Assessment label: Week 4 Assignment – Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders

Length: 1–2 page paper (excluding title page and references), approximately 500–700 words, APA 7th edition format

Weighting: Major weekly assignment aligned with GI/hepatobiliary pharmacology module and practicum application outcomes

Assignment Overview

Gastrointestinal (GI) and hepatobiliary disorders frequently present with overlapping symptoms such as abdominal pain, nausea, vomiting, changes in bowel habits, fatigue, and weight changes, which can stem from infections, inflammatory conditions, metabolic liver disease, malignancy, pregnancy, medications, or substance use disorders. Accurate pharmacologic management requires that advanced practice nurses discriminate between similar presentations, determine whether symptoms originate from the GI or hepatobiliary system or reflect pathology in another system, and then select targeted therapies consistent with current evidence-based guidelines and the patient’s comorbidities and concurrent drugs. In this Week 4 Assignment, you will analyze an assigned case study, justify a primary diagnosis, and design a focused pharmacotherapy plan that considers the patient’s current regimen, risks, and safety monitoring needs.

Case Study Selection (Instructor-Assigned)

Your instructor will assign you one of the Week 4 GI or hepatobiliary case studies for NURS 6521. Only use the case you have been given in your section and do not switch or combine cases. Carefully review the full case details posted in your course shell, including symptoms, timeline, social history, substance use, pregnancy status where relevant, home medications, allergies, and pertinent lab or imaging data. Your analysis and drug therapy plan must be tailored to that specific patient profile.

Assignment Instructions

Write a 1–2 page academic paper that addresses the following components for your assigned patient:

1. Diagnosis and Rationale

• State your primary working diagnosis using appropriate clinical terminology.
• Briefly list 1–2 key differential diagnoses and justify why they were ruled out based on case data.
• Explain your rationale by linking patient history, clinical findings, and pathophysiology.

2. Drug Therapy Plan

• Describe an evidence-based pharmacotherapy plan aligned with current clinical guidelines.
• For each medication include:
  • Drug name (generic preferred)
  • Dose, route, and frequency
  • Duration or taper schedule
  • Key patient counseling points
• Clarify which current medications to continue, discontinue, or adjust.
• Address supportive therapies such as rehydration, antiemetics, acid suppression, or safe analgesia.

3. Justification of Plan

• Justify therapy based on patient history, comorbidities, and risk factors.
• Discuss at least two safety considerations such as drug interactions or monitoring needs.
• Provide examples showing how your plan reduces complications.

4. Application of Evidence and Guidelines

• Connect your plan to at least one current evidence-based guideline.
• Use at least two scholarly or guideline references published between 2018 and 2026.

Formatting and Submission Requirements

• APA 7th edition formatting
• Title page, introduction, structured body headings, and conclusion
• Reference list with at least two current scholarly sources
• Submit as a Microsoft Word document by Day 7

Marking Criteria / Week 4 Assignment Rubric (2026)

Academic Integrity Note

Use course materials and scholarly sources to support your work. Avoid copying from online repositories. Paraphrase appropriately and cite all sources. Your submission must reflect your own clinical reasoning.

Additional Academic Insight

Effective pharmacotherapy in gastrointestinal and hepatobiliary disorders requires a structured clinical reasoning process that integrates diagnostic accuracy with patient-specific safety considerations and guideline adherence. Advanced practice nurses must evaluate pharmacokinetic and pharmacodynamic variables alongside comorbid conditions to ensure optimal therapeutic outcomes while minimizing adverse effects. This includes careful assessment of hepatic metabolism, potential drug interactions, and the appropriateness of supportive care interventions such as fluid management and symptom control. Incorporating evidence-based recommendations into individualized care plans strengthens clinical decision-making and improves patient outcomes in complex presentations (Riddle & DuPont, 2019).

References

• AASLD–IDSA. (2024). HCV guidance: Recommendations for testing, managing, and treating hepatitis C.
• Chalasani, N., et al. (2018). Diagnosis and management of nonalcoholic fatty liver disease. Hepatology.
• Riddle, M. S., & DuPont, H. L. (2019). Acute infectious diarrhea. JAMA.
• Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics. Elsevier.
• World Gastroenterology Organisation. (2018). Acute diarrhea global guidelines.
•  Lacy, B. E., et al. (2021). ACG clinical guideline for management of dyspepsia. American Journal of Gastroenterology.
• Write a 500–700 word APA 7 paper for NURS 6521 Week 4 covering GI and hepatobiliary diagnosis, pharmacotherapy plan, and evidence-based justification.

• Complete your Week 4 advanced pharmacology assignment with a structured GI or hepatobiliary case analysis, including diagnosis and drug therapy plan.
• Graduate nursing guide for NURS 6521 Week 4 with rubric, pharmacotherapy strategies, and clinical reasoning tips.

~~~~

Assignment: Week 5 Discussion – Pharmacotherapy for Endocrine Disorders

NURS 6521 Week 5 Discussion – Pharmacotherapy for Endocrine Disorders Description: In Week 5, you will shift from GI and hepatobiliary conditions to endocrine disorders such as type 2 diabetes, thyroid disease, or adrenal dysfunction, using short case vignettes similar to prior discussion formats. Your initial discussion post (300–500 words) will require you to select one assigned case, state your most likely endocrine diagnosis, and propose an appropriate first‑line pharmacologic regimen with dosing, monitoring, and patient teaching. You will then compare your approach with at least one classmate’s plan in two substantive peer responses, focusing on differences in drug selection, safety considerations, and guideline use. APA citations are expected in the initial post, and responses should extend the discussion rather than repeat original points.